Clinical Trial Manager
Triveni Bio
Clinical Trial Manager
Triveni Bio
Develops functional antibodies for precision medicine
Salary Range: 70 to 76 (Currency: USD) (Pay period: per-hour-wage)
SUMMARY
The Clinical Trial Manager (CTM) will be responsible for the management of clinical trials from start-up to close-out. This position will manage the day-to-day operations of assigned clinical trials ensuring they are conducted in compliance with Good Clinical Practice (GCP), regulatory guidelines, and company policies. The CTM will collaborate with cross-functional teams to ensure the trials are delivered on time, within budget, and to the highest quality standards.
On a day-to-day basis, you will be part of a high performing team and will be responsible for managing clinical trial operations for one or more studies while working closely with the Clinical Study Team.
The ideal candidate is an adaptable and resilient Clinical Trial Manager who is interested in working in a fast-paced, dynamic, collaborative biotech environment with a willingness and ability to contribute to the growth of the function and take on new challenges successfully. The candidate will work among a cross-functional Study Team from feasibility through study closeout. Prior experience in recruitment and retention tactics and site relationship management is a plus.
You must have experience managing phase 1/2 trials and be comfortable with executing all operational aspects of clinical trials inclusive of clinical vendor management. May be responsible for managing multiple clinical trials with varying levels of complexity.
This is a contract role with the potential to go permanent.
RESPONSIBILITIES
Trial Management & Execution:
Site Management:
Data Quality & Monitoring:
Compliance & Regulatory Oversight:
Vendor & CRO Management:
Reporting & Documentation:
EXPERIENCE & QUALIFICATIONS
Develops functional antibodies for precision medicine
Triveni Bio develops therapeutics by creating functional antibodies for immunological and inflammatory disorders using genetics-informed precision medicine in a B2B licensing model. Using a proprietary platform, it identifies targets with strong genetic rationale, designs and validates antibodies against them, and predicts patient subpopulations to understand disease mechanisms. It differentiates itself by combining genetics-backed target discovery, functional antibody development, and patient stratification in a single platform, reducing risks for novel targets. Its goal is to supply the biopharmaceutical industry with precise antibody therapies and related technologies to enable targeted treatments for defined patient groups.
Explore more opportunities at Triveni Bio